[{"AccountsPayableCurrent_0_Q3_USD":11499000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":20710000.0,"PaymentsToAcquireInvestments_3_Q3_USD":474801000.0,"PaymentsToAcquireEquityMethodInvestments_3_Q3_USD":15938000.0,"PaymentsForProceedsFromTenantAllowance_3_Q3_USD":1111000.0,"PaymentsForLeasingCostsCommissionsAndTenantImprovements_3_Q3_USD":4058000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":1528000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":393000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":5175000.0,"OtherExpenses_3_Q3_USD":1766000.0,"OtherExpenses_1_Q3_USD":909000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-666000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-64000.0,"OtherAssetsNoncurrent_0_Q3_USD":6160000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0843,"OperatingLeaseRightOfUseAsset_0_Q3_USD":38764000.0,"OperatingLeasePayments_3_Q3_USD":4100000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":50639000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3235000.0,"OperatingLeaseLiability_0_Q3_USD":53874000.0,"OperatingLeaseExpense_3_Q3_USD":2622000.0,"OperatingLeaseCost_3_Q3_USD":5568000.0,"OperatingLeaseCost_1_Q3_USD":1853000.0,"OperatingIncomeLoss_3_Q3_USD":-181899000.0,"OperatingIncomeLoss_1_Q3_USD":-77670000.0,"OperatingExpenses_3_Q3_USD":220337000.0,"OperatingExpenses_1_Q3_USD":77719000.0,"NonoperatingIncomeExpense_3_Q3_USD":-238000.0,"NonoperatingIncomeExpense_1_Q3_USD":-516000.0,"NetIncomeLoss_3_Q3_USD":-182137000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"NetIncomeLoss_1_Q3_USD":-78186000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":134690310.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":137025698.0,"VariableLeaseCost_3_Q3_USD":979000.0,"VariableLeaseCost_1_Q3_USD":448000.0,"TenantImprovements_0_Q3_USD":5000000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":8023000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":750000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":3617000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":1632000.0,"StockholdersEquity_0_Q3_USD":969942000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_3_Q3_USD":2706000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q3_USD":1142000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensation_3_Q3_USD":58782000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":38438000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":49000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-828480000.0,"RestrictedCashNoncurrent_0_Q3_USD":9449000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":166193000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":58720000.0,"PurchaseCommitmentRemainingMinimumAmountCommitted_0_Q3_USD":2900000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":125883000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":145002000.0,"ProfitLoss_3_Q3_USD":-182137000.0,"ProceedsFromStockPlans_3_Q3_USD":3617000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":645854000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":8024000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":19373000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-139376000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":134405000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":11641000.0,"CommonStockValue_0_Q3_USD":142000.0,"CommonStockSharesOutstanding_0_Q3_shares":142439829.0,"CommonStockSharesIssued_0_Q3_shares":142439829.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":16937335.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashEquivalentsAtCarryingValue_0_Q3_USD":134803000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":6670000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":199470000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":861700000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":190021000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":1112000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":378222000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":293464000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":806445000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":228000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":272000.0,"AssetsCurrent_0_Q3_USD":502858000.0,"Assets_0_Q3_USD":1079246000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":17865667.0,"AmortizationOfIntangibleAssets_3_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":58782000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":20856000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":58782000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":20856000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1798678000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-398000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":19119000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-78250000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-182803000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":365000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":53490000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1079246000.0,"Liabilities_0_Q3_USD":109304000.0,"LettersOfCreditOutstandingAmount_0_Q3_USD":5200000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":28917000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1949000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":8168000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":8430000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":8509000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":7917000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":83116000.0,"LeaseCost_3_Q3_USD":6547000.0,"LeaseCost_1_Q3_USD":2301000.0,"InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0_Q3_USD":17910000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":137025698.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":-5361000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":2092000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":991000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-38627000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":6420000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1277000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":54144000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":18999000.0,"EarningsPerShareDiluted_3_Q3_USD":-1.35,"EarningsPerShareDiluted_1_Q3_USD":-0.57,"EarningsPerShareBasic_3_Q3_USD":-1.35,"EarningsPerShareBasic_1_Q3_USD":-0.57,"Depreciation_3_Q3_USD":6212000.0,"DeferredCompensationShareBasedArrangementsLiabilityCurrent_0_Q3_USD":3600000.0,"DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent_0_Q3_USD":3000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2153000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":134690310.0,"Ticker":"ALLO","CIK":"1737287","name":"ALLOGENE THERAPEUTICS, INC.","OfficialName":"Allogene Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1134878416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]